eISSN : 2146-9369
Creative Commons Lisansı
Journal of Clinical and Experimental Investigations is licenced under the terms of Creative Commons Attribution-Non Commercial4.0 International (CC BY-NC 4.0) License.
Abstract - Hepatitis B and C Seroprevalence in Leprosy Patients
Türkkan Öztürk Kaygusuz, Müge Özgüler, Leyla Saltık Güngör, Çiğdem Papila

Müge Özgüler,

Elazıg Education and Research Hospital, Department of Infectious Diseases, 23100 Elazıg, Turkey   

Hepatitis B and C Seroprevalence in Leprosy Patients

ABSTRACT

Objective: Leprosy is a contagious chronic granulomatous disease and commonly affects the eyes and the internal organs. Leprosy can be classified according to the level of immune response. Leprosy is a disease that is associated with defects in cellular immunity. This is why we have investigated the leprosy patients that were referred to our hospital for chronic hepatitis B and C co-infections.

Methods: Fifty patients who were treated in the leprosy unit of Elazığ Research and Training hospital between the dates of June-December 2011 were enrolled to this descriptive study. Macro ELISA assay was performed for Hepatitis B,C and HIV.

Results: Fifty patients who were treated in the leprosy unit of our hospital participated in the study. A total of 8% HBsAg presence was noted. A total of 16 Anti HCV presence was noted in the patient group. Anti HCV positivity was deter­mined at seven of 14 patients with tuberculoid form leprosy (50%) and nine of 33 lepromatous leprosy form (27,2%).

Conclusion: In conclusion, leprosy patients, especially lepromatous leprosy group, are immunologically vulnerable to HBV and HCV co-infections. Thus, physicians should be aware of HBV coinfections in these patients and education should be given to patients to increase their knowledge regarding risky situations for transmission of the disease. J Microbiol Infect Dis 2015;5(3): 114-118

Müge Özgüler, Elazıg Education and Research Hospital, Department of Infectious Diseases, 23100 Elazıg, Turkey , Hepatitis B and C Seroprevalence in Leprosy Pat, Müge Özgüler, Elazıg Education and Research Hospital, Department of Infectious Diseases, 23100 Elazıg, Turkey  J Microbiol Infect Dis 2015;5(3): 114-118 doi: 10.5799/ahinjs.02.2015.03.0188

Volume 05, Number 03 (2015)

Volume 05, Number 03 (2015)